Tag: Belén Sánchez

AMP-activated kinase as a therapeutic target in prostate cancer

Written by
Prostate cancer is one of the leading causes of mortality among men worldwide.

Pharmacological treatment of prostate cancer has advanced significantly in recent years. However, while the newest therapies are initially effective in reducing tumour size, most patients eventually develop drug resistance and the recurrence of malignant spread. Professor Inés Díaz-Laviada and her team at the Alcala University in Madrid, Spain, have demonstrated that long-term treatments may induce the transformation of cancer cells […]

Read More… from AMP-activated kinase as a therapeutic target in prostate cancer